Heart surgery patients may get a patch to stop dangerous rhythm problems
NCT ID NCT06722196
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether placing a biodegradable patch soaked with the drug amiodarone on the heart during surgery can prevent atrial fibrillation (a common irregular heartbeat) afterward. About 500 adults having elective heart surgery will be randomly assigned to get either the amiodarone patch or a plain saline patch. The goal is to see if the drug patch reduces the number of patients who develop atrial fibrillation while in the hospital.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
amiodarone
What this could lead to
If it works, this could provide a simple, targeted way to prevent dangerous heart rhythm problems after cardiac surgery, reducing complications and hospital stays.
What could go wrong
This is still an early-phase trial with 500 participants, so results may not apply to all patients. The patch could cause side effects like inflammation or bleeding, and it may not reduce AF as hoped.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Jilin Heart Hospital
RECRUITINGChangchun, Jinlin, 130000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••